Tingson, Jerick R.

HRN: 06-58-34  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2026
CEFTRIAXONE 1G (VIAL)
06/06/2026
06/13/2026
IV
2g
OD
Maxillary Abscess
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines